Creative Writing


of 4
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
  GAMP 5   A Risk-Based Approach toCompliant GxP Computerized Systems  Disclaimer: This Guide is meant to assist pharmaceutical manufacturing companies in managing GxP Regulated systems. ISPEcannot ensure and does not warrant that a system managed in accordance with this Guide will be acceptable toregulatory authorities. Further, this Guide does not replace the need for hiring  professional engineers or technicians. Limitation of LiabilityIn no event shall ISPE or any of its affiliates, or the officers, directors, employees, members, or agents of each of them, be liable for any damages of any kind, including without limitation any special, incidental, indirect, or consequential damages, whether or not advised of the possibility of such damages, and on any theory of liabilitywhatsoever, arising out of or in connection with the use of this information. © Copyright ISPE 2008. All rights reserved. All rights reserved. No part of this document may be reproduced or copied in any form or by any means  –   graphic,electronic, or mechanical, including  photocopying, taping, or information storage and retrieval systems  –   withoutwritten permission of ISPE. All trademarks used are acknowledged.ISBN 1-931879- 77-X GAMP 5   A Risk-Based Approach toCompliant GxP Computerized Systems  For individual use only. © Copyright ISPE 2008. All rights reserved.  Advertisement Page 2 GAMP 5 A Risk-Based Approach to Compliant GxP Computerized Systems Foreword Changing Environment  –   Regulatory and Industry Initiatives The pharmaceutical industry is responding to the challenge of significantly improving the way drug development andmanufacturing is managed.New concepts are being developed and applied, including science based risk management approaches, a focus onproduct and process understanding, and the application of Quality by Design concepts.Many of these ideas are defined and described in the FDA 21 st   Century Initiative, new ICH documents such as Q8Pharmaceutical Development, Q9 Quality Risk Managemen t, and Q10 Pharmaceutical Quality System, ISPE’sProduct Quality Lifecycle Implementation (PQLI) initiative, and various supporting industry consensus standards,such as the ASTM E2500 Standard Guide for Specification, Design, and Verification of Pharmaceutical andBiopharmaceutical Manufacturing Systems and Equipment . As these new ideas and ways of working are being established, the industry will for some time be in a  period of transition.GAMP ® guidance must evolve to meet the needs of the changing environment, and integrate fully with ISPEinitiatives such as PQLI, and the revision of the ISPE Baseline ® Guide on Commissioning and Qualification. There isboth a need and an opportunity to make activities related to all types of computerized systems efficient, effective,and focused on patient safety.  New and Innovative Approaches Where a computer system is regarded as one component of a wider manufacturing process or system,  particularly inan integrated Quality by Design environment, specific and separate computerized system validation may not benecessary. This environment requires both complete product and process understanding and that the critical processparameters can be accurately and reliably predicted and controlled over the design space. In such a case, thefitness for intended use of the computer system within the process may be adequately demonstrated by documentedengineering or project activities together with subsequent Process Validation or continuous quality verification of theoverall process or system. The same principle applies to the adoption of Process Analytical Technology (PAT).These innovative approaches are available and useable now if the appropriate pre-requisites are met. Whileacknowledging that not all regulated companies will be in a position to, or will choose to, fully embrace the newapproaches immediately, this Guide is intended to encourage the adoption of such approaches and in no way to be abarrier. Improving Quality Practice   During the period of transition, the industry continues to need practical guidance based on current good  practice  –  giving practitioners the tools to do the job today, while building a bridge to new approaches. This Guide aims todescribe current good practice in order to satisfy the needs of the majority of  practitioners involved withcomputerized systems, while also enabling new and innovative approaches, e.g., for process systems in a Quality byDesign environment. These innovative approaches and the application of principles to specific system types will beexplored in detail in subsequent documents.In the meantime, key aspects supportive of ISPE PQLI and ASTM E2500 are addressed immediately to make currentactivities as effective and efficient as possible. These include: For individual use only. © Copyright ISPE 2008. All rights reserved.


Jul 23, 2017
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks